OxyContin manufacturer placed profits on people, the lawsuit reveals

NASHVILLE, Tennessee – A recent lawsuit filed by the Attorney General of Tennessee states that the world's best-selling painkiller manufacturer has led its sales force to target the largest prescribers, many of whom are noncompliant. had no history or no training in pain management. Quoting the public's right to know, Attorney General Herbert Slatery said Thursday that the manufacturer of OxyContin, Purdue Pharma, had abandoned its previous efforts to conceal the details of the 274-page trial in a state court. . The Tennessee coalition for open government and the Knoxville News Sentinel had also requested that the trial files become public.

The lawsuit says that Purdue violated a 2007 settlement with the state, placing profits on people with a misleading narrative that claimed his opioids that they actually were. The lawsuit also said that the Stamford, Connecticut-based company was targeting vulnerable people, including the elderly.

Purdue did so relying on continuous users and high doses, according to the lawsuit: 104.3 million OxyContin tablets were prescribed in Tennessee 2017, with 53.7% of 39, between them 40 milligrams or more. For example, Purdue appealed to two suppliers 48 times after law enforcement authorities told Purdue that the pair was responsible for a major hijacking of OxyContin interstate, the trial said. . The company relied on another provider 31 times after the supplier's license was placed on restrictive probation related to the high prescription of controlled substances, adds the lawsuit

.

"Purdue continued to make visits despite credible reports of overdoses, charges, and actions of homologation, a provider admitting that he was addicted to Heroin, a knife fight in front of a vendor's office, theft of controlled substances outside a pharmacy bound to a specific provider, a clinic that did not have any examination tables or equipment, an admission by a provider that he was running a pillbox, a provider changing the name of his practice shortly after being informed of a state inquiry into his practice , a patient is guided into the waiting room to find out how to fill in the admission forms, armed guards in the waiting rooms of the providers, a large number of patients who p bought OxyContin in cash , a large number of labels out of the state or out of the country in station parks. t vendors, insurance fraud charges, choreographic urine tests and pills, permanent waiting rooms and additional signs of "19659002] Purdue denied claims in the Trial at the national level over the plague of opioid abuse, saying that he will defend himself. In Tennessee, there were 1631 overdose deaths in 2016, including 1,186 opioids, according to the Ministry of Health.

Tennessee filed its lawsuit last month along with Florida, North Carolina, North Dakota and Texas. claims for unfair and deceptive marketing practices.